1. Home
  2. JJSF vs DVAX Comparison

JJSF vs DVAX Comparison

Compare JJSF & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo J & J Snack Foods Corp.

JJSF

J & J Snack Foods Corp.

HOLD

Current Price

$96.79

Market Cap

1.7B

ML Signal

HOLD

Logo Dynavax Technologies Corporation

DVAX

Dynavax Technologies Corporation

HOLD

Current Price

$15.63

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JJSF
DVAX
Founded
1971
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
JJSF
DVAX
Price
$96.79
$15.63
Analyst Decision
Strong Buy
Hold
Analyst Count
3
5
Target Price
$138.33
$26.50
AVG Volume (30 Days)
206.0K
5.6M
Earning Date
02-02-2026
02-19-2026
Dividend Yield
3.30%
N/A
EPS Growth
N/A
N/A
EPS
3.36
N/A
Revenue
$1,583,233,000.00
$330,514,000.00
Revenue This Year
$4.28
$24.63
Revenue Next Year
$2.24
$15.85
P/E Ratio
$28.90
N/A
Revenue Growth
0.54
26.73
52 Week Low
$80.67
$9.20
52 Week High
$146.67
$15.73

Technical Indicators

Market Signals
Indicator
JJSF
DVAX
Relative Strength Index (RSI) 62.96 85.75
Support Level $92.94 $15.57
Resistance Level $98.43 $15.73
Average True Range (ATR) 2.29 0.06
MACD 0.67 -0.05
Stochastic Oscillator 82.86 70.83

Price Performance

Historical Comparison
JJSF
DVAX

About JJSF J & J Snack Foods Corp.

J&J Snack Foods Corp. manufactures snack foods and distributes frozen beverages, which it markets nationally to the foodservice and retail supermarket industries. The company's portfolio of frozen beverages, frozen novelties, and baked goods includes soft pretzels, frozen juice treats and desserts, stuffed sandwiches, churros, funnel cakes, cookies, and other snack foods and drinks. It operates through three segments: Food Service, which sells snacks, desserts, and baked goods at the point of sale; Retail Supermarkets, which sells frozen and prepackaged products to supermarkets; and Frozen Beverages, which sells frozen beverages under the ICEE, Slush Puppie, and Parrot Ice brands in the United States, Mexico, and Canada. The majority of revenue comes from the Food Service segment.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: